GlassScriptPhysician profile
Whitney Messer Abel
NPI 1134792211
$1,807.63
in general payments reported to CMS, 2019-2025
13 companies · $930 in 2025
The $930 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $233 · 2023: $336 · 2024: $309 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,401 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,400.74 |
| Education | $173.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $542.87 | 2022-2025 | Enhertu, Datroway |
| Tactile Systems Technology INC | $187.47 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $139.58 | 2025 | |
| Deciphera Pharmaceuticals INC. | $130.69 | 2024 | Qinlock |
| Exelixis INC. | $125.01 | 2025 | Cabometyx |
| Ipsen Biopharmaceuticals, INC | $114.24 | 2025 | Onivyde |
| E.R. Squibb & Sons, L.L.C. | $108.49 | 2025 | Opdivo |
| Astellas Pharma US INC | $95.30 | 2025 | Vyloy |
| Gilead Sciences, INC. | $94.20 | 2024 | Trodelvy |
| Takeda Pharmaceuticals U.S.A., INC. | $88.43 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $84.36 | 2022 | |
| Abbvie INC. | $81.53 | 2025 | |
| Sanofi Pasteur INC. | $15.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Abel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.